My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Volumes jump at Relaxo Footwears counter
Mar 14,2017

Relaxo Footwears clocked volume of 16.86 lakh shares by 14:47 IST on BSE, a 783.55-times surge over two-week average daily volume of 2,152 shares. The stock rose 4.83% to Rs 465.50.

IST notched up volume of 64,000 shares, a 176.52-fold surge over two-week average daily volume of 362 shares. The stock was unchanged at Rs 790.

OCL India saw volume of 2.82 lakh shares, a 123.94-fold surge over two-week average daily volume of 2,277 shares. The stock rose 1.52% to Rs 920.

Polaris Consulting & Services clocked volume of 5.99 lakh shares, a 35.12-fold surge over two-week average daily volume of 17,000 shares. The stock rose 1.91% to Rs 184.25.

Metalyst Forgings saw volume of 29.66 lakh shares, a 32.28-fold rise over two-week average daily volume of 92,000 shares. The stock rose 3.99% to Rs 62.60.

Powered by Capital Market - Live News

Kalyani Forge drops on profit booking
Mar 14,2017

Meanwhile, the S&P BSE Sensex was up 505.29 points, or 1.75% to 29,451.52

On BSE, so far 1,455 shares were traded in the counter, compared with average daily volume of 1,674 shares in the past one quarter. The stock hit a high of Rs 409 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 375 so far during the day. The stock had hit a 52-week low of Rs 220.30 on 2 June 2016.

The stock had outperformed the market over the past 30 days till 10 March 2017, rising 34.72% compared with the 2.18% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 39.54% as against Sensexs 8.22% gain.

The small-cap companys equity capital is Rs 3.64 crore. Face value per share is Rs 10.

Kalyani Forges net profit surged 109.76% to Rs 1.72 crore on 3.25% rise in net sales to Rs 55.86 crore in Q3 December 2016 over Q3 December 2015.

Kalyani Forge is an engineering company with an expertise in metal forming. The company makes forged, machined and assembled products for a variety of customers in industries like automotive, construction, power generation, marine, railway, and industrial goods.

Powered by Capital Market - Live News

Sun Pharma jumps as USFDA to lift import alert on Mohali unit
Mar 14,2017

The announcement was made during trading hours today, 14 March 2017.

Meanwhile, the S&P BSE Sensex was up 514.35 points, or 1.78% to 29,460.58.

On the BSE, 10.36 lakh shares were traded in the counter so far, compared with average daily volumes of 3.82 lakh shares in the past one quarter. The stock had hit a high of Rs 728.45 and a low of Rs 678.10 so far during the day. The stock hit a 52-week high of Rs 876 on 14 March 2016. The stock hit a 52-week low of Rs 572.40 on 9 November 2016.

The stock had outperformed the market over the past one month till 10 March 2017, rising 4.08% compared with 2.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 1.57% as against Sensexs 8.22% rise.

The large-cap company has equity capital of Rs 239.93 crore. Face value per share is Re 1.

Sun Pharmaceuticals Industries (Sun Pharma) was informed by the US Food and Drug Administration (US FDA) that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the Official Action Initiated (OAI) status. This proposed action will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market, subject to normal US FDA regulatory requirements.

The Mohali facility was inherited by Sun Pharma as part of its acquisition of Ranbaxy Laboratories in 2015. The US FDA had taken action against the Mohali facility in 2013 when it ordered the facility to be fully subject to Ranbaxys Consent Decree of Permanent Injunction. Certain conditions of the consent decree will continue to be applicable to the Mohali facility.

This development illustrates Sun Pharmas commitment to work closely with the US FDA and strive for 100% cGMP compliance at its manufacturing facilities.

On a consolidated basis, Sun Pharmaceuticals Industries net profit declined 11.23% to Rs 1721.85 crore on 8.41% rise in net sales to Rs 7683.24 crore in Q3 December 2016 over Q3 December 2015.

Sun Pharma is the worlds fourth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Gujarat Fluorochemicals gains on report of rejig
Mar 14,2017

Meanwhile, the S&P BSE Sensex was up 529.40 points, or 1.83% to 29,475.63.

On the BSE, 43,000 shares were traded in the counter so far, compared with average daily volumes of 25,608 shares in the past one quarter. The stock had hit a high of Rs 621 and a low of Rs 595.50 so far during the day. The stock hit a 52-week high of Rs 666.65 on 27 July 2016. The stock hit a 52-week low of Rs 451 on 9 November 2016.

The stock had outperformed the market over the past one month till 10 March 2017, rising 19.86% compared with 2.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 24.35% as against Sensexs 8.22% rise.

The mid-cap company has equity capital of Rs 10.99 crore. Face value per share is Re 1.

According to the media report, Gujarat Fluorochemicals plans to make its structure a simpler one. The focus will be on restructuring the chemical business and remove the holding company discount. As part of the strategy, the firm will demerge its chemicals business into a separate entity. Currently, the company has four verticalsn++chemicals, wind turbine manufacturing, wind farm, film exhibition.

On the financial front, the companys standalone specialty chemical business is valued at Rs 5000 crore, while its market capitalisation is seen at Rs 6500 crore, the report added.

On a consolidated basis, net profit of Gujarat Fluorochemicals declined 7.69% to Rs 73.38 crore on 16.79% rise in net sales to Rs 1790.21 crore in Q3 December 2016 over Q3 December 2015.

Gujarat Fluorochemicals, a part of the INOX Group of companies, makes fluoropolymers, fluoroelastomer, fluoroadditives, fluorospeciality chemicals, refrigerants and chemicals.

Powered by Capital Market - Live News

IL&FS Transportation advances after divestment of stake in Andhra Pradesh Expressway
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 461 points, or 1.59%, to 29,407.23

On BSE, so far 32,000 shares were traded in the counter, compared with average daily volume of 1.27 lakh shares in the past one quarter. The stock hit a high of Rs 104.90 and a low of Rs 101.60 so far during the day.

The stock hit a 52-week high of Rs 124.80 on 12 January 2017. The stock hit a 52-week low of Rs 65.85 on 19 August 2016. The stock had underperformed the market over the past 30 days till 10 March 2017, sliding 6.57% compared with the 2.18% rise in the Sensex. The scrip also underperformed the market in past one quarter, falling 5.38% as against Sensexs 8.22% gain.

The mid-cap company has equity capital of Rs 328.96 crore. Face value per share is Rs 10.

IL&FS Transportation Networks had entered into share purchase agreement on 24 August 2016 with Cube Highways & Infrastructure Pte., a company incorporated in Singapore for sale of its entire equity stake in Andhra Pradesh Expressway for an aggregate value of Rs 140.37 crore.

IL&FS Transportation Networks reported net profit of Rs 55.66 crore in Q3 December 2016 as against net loss of Rs 19.42 crore in Q3 December 2015. Net sales dropped 23.8% to Rs 763 crore in Q3 December 2016 over Q3 December 2015.

IL&FS Transportation Networks has grown into the largest BOT (build, operate and transfer) road assets owner in India.

Powered by Capital Market - Live News

Gitanjali Gems jumps after subsidiary files for IPO
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 482.34 points, or 1.67% to 29,428.57.

On the BSE, 1.85 lakh shares were traded in the counter so far, compared with average daily volumes of 3.06 lakh shares in the past one quarter. The stock had hit a high of Rs 68.65 and a low of Rs 66.25 so far during the day. The stock hit a 52-week high of Rs 93.60 on 10 October 2016. The stock hit a 52-week low of Rs 31.55 on 18 March 2016.

The stock had underperformed the market over the past one month till 10 March 2017, falling 12.80% compared with 2.18% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 5.41% as against Sensexs 8.22% rise.

The small-cap company has equity capital of Rs 118.62 crore. Face value per share is Rs 10.

Gitanjali Gems announced that Nakshatra World (NWL) (formerly known as Gitanjali Brands), a wholly-owned subsidiary of the company, has filed its draft red herring prospectus dated 8 March 2017, for an initial public offering (IPO) with the Securities and Exchange Board of India (Sebi) as well as with both the stock exchanges i.e. BSE and National Stock Exchange of India.

On a consolidated basis, net profit of Gitanjali Gems declined 23.62% to Rs 57.63 crore on 1.37% decline in net sales to Rs 3352.97 crore in Q3 December 2016 over Q3 December 2015.

Gitanjali Gems is engaged in diamond cutting and polishing, and diamond and gold jewelry manufacturing.

Powered by Capital Market - Live News

Oil India moves higher as board to consider share buyback proposal
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 486.25 points, or 1.68%, to 29,432.48

On BSE, so far 32,000 shares were traded in the counter, compared with average daily volume of 52,122 shares in the past one quarter. The stock hit a high of Rs 340 and a low of Rs 332.30 so far during the day.

The stock hit a 52-week high of Rs 367.43 on 11 January 2017. The stock hit a 52-week low of Rs 226.50 on 16 March 2016. The stock had underperformed the market over the past 30 days till 10 March 2017, sliding 3.07% compared with the 2.18% rise in the Sensex. The scrip also underperformed the market in past one quarter, gaining 0.72% as against Sensexs 8.22% gain.

The large-cap company has equity capital of Rs 801.51 crore. Face value per share is Rs 10.

Oil Indias net profit rose 18.82% to Rs 454.69 crore on 7.1% rise in net sales to Rs 2376.37 crore in Q3 December 2016 over Q3 December 2015.

Oil India is a premier oil company engaged in the business of exploration, development and production of crude oil and natural gas, transportation of crude oil and production of LPG. The company also provides various E&P related services and holds 26% equity in Numaligarh Refinery.

The Government of India held 67.64% stake in Oil India as per the shareholding pattern as on 16 January 2017.

Powered by Capital Market - Live News

Satin Creditcare advances as board approves fund raising plan
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 493.69 points or 1.71% at 29,439.92

On BSE, so far 18,000 shares were traded in the counter as against average daily volume of 24,390 shares in the past one quarter. The stock hit a high of Rs 405 and a low of Rs 386.10 so far during the day.

The stock had hit a record high of Rs 716.70 on 28 July 2016. The stock had hit a 52-week low of Rs 289.90 on 29 March 2016. The stock had underperformed the market over the past 30 days till 10 March 2017, sliding 13.87% compared with the 2.18% rise in the Sensex. The scrip also underperformed the market in past one quarter, gaining 0.5% as against Sensexs 8.22% gain.

The small-cap company has equity capital of Rs 37.57 crore. Face value per share is Rs 10.

Satin Creditcare Networks board of directors at its meeting held on 10 March 2017 approved issue of 6.58 lakh warrants convertible into equivalent number of equity shares of the company to Trishashna Holding and Investments under promoter category at Rs 455.45 per share. The companys board also approved issue of 15.99 lakh shares to Asian Development Bank at Rs 416.67 per share under non-promoter / public category (qualified institutional buyer).

Satin Creditcare Networks net profit rose 9.53% to Rs 16.44 crore on 44.83% growth in total income to Rs 208.35 crore in Q3 December 2016 over Q3 December 2015.

Satin Creditcare Network is the fifth largest microfinance institution in terms of gross lending portfolio (GLP) as on 31 March 2016 with a strong presence in north India.

Powered by Capital Market - Live News

Bitter pill for Alkem Labs after receiving USFDA observations for Baddi facility
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 487.58 points or 1.68% at 29,433.81

On the BSE, 4,591 shares were traded on the counter so far as against the average daily volumes of 8,866 shares in the past one quarter. The stock had hit a high of Rs 1,989.95 and a low of Rs 1,922.10 so far during the day.

The stock had hit a record high of Rs 2187 on 27 Februray 2017. The stock had hit a record low of Rs 1,175 on 2 May 2016. The stock had outperformed the market over the past 30 days till 10 March 2017, rising 8.95% compared with the 2.18% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 17.74% as against Sensexs 8.22% gain.

The large-cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 2.

Alkem Laboratories said that the United States Food & Drug Administration (USFDA) had conducted an inspection at the companys manufacturing facility located at Baddi from 2 March 2017 to 10 March 2017. In this regard, the company has received the inspection report which contains three 483 observations. The company shall put together a detailed response with adequate corrective and preventive measures to address the USFDA observations and the same is proposed to be filed within the timeline stipulated by USFDA.

Alkem Laboratories consolidated net profit rose 24.89% to Rs 233.40 crore on 15.42% growth in total income to Rs 1507.32 crore in Q3 December 2016 over Q3 December 2015.

Alkem Laboratories is a pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Powered by Capital Market - Live News

Marathon Nextgen Realty spurts on buyback plan
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 489.82 points, or 1.69% to 29,436.05.

On the BSE, 31,000 shares were traded in the counter so far, compared with average daily volumes of 2,917 shares in the past one quarter. The stock had hit a high of Rs 260 and a low of Rs 234.10 so far during the day. The stock hit a 52-week high of Rs 297 on 12 August 2016. The stock hit a 52-week low of Rs 135 on 5 April 2016.

The stock had outperformed the market over the past one month till 10 March 2017, rising 6.38% compared with 2.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 1.61% as against Sensexs 8.22% rise.

The small-cap company has equity capital of Rs 28.44 crore. Face value per share is Rs 10.

Marathon Nextgen Realty said that the board will also consider new project proposal, among other things.

Net profit of Marathon Nextgen Realty declined 22.20% to Rs 25.16 crore on 36.4% decline in net sales to Rs 53.81 crore in Q3 December 2016 over Q3 December 2015.

Marathon Nextgen Realty is engaged in real estate development business.

Powered by Capital Market - Live News

Karnataka Bank gains after tie-up with Bajaj Allianz for general insurance biz
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P Sensex was up 487.57 points, 1.68% to 29,433.80.

On the BSE, 1.85 lakh shares were traded on the counter so far as against the average daily volumes of 3.28 lakh shares in the past one quarter. The stock had hit a high of Rs 141.30 and a low of Rs 138 so far during the day.

The stock had hit a 52-week high of Rs 143.35 on 2 March 2017 and a 52-week low of Rs 75.34 on 11 March 2016. The stock had outperformed the market over the past one month till 10 March 2017, advancing 14.91% compared with the Sensexs 2.16% rise. The scrip had also outperformed the market over the past one quarter advancing 27.95% as against the Sensexs 8.22% rise.

The mid-cap bank has equity capital of Rs 282.70 crore. Face value per share is Rs 10.

Karnataka Bank announced that the bank entered into Memorandum of Understanding with Bajaj Allianz General Insurance Company (BAGICL) for general insurance business.

Karnataka Banks Managing Director & CEO P Jayaram Bhat said the bank will be able to provide vast choice of non-life insurance products to its customers across all its 747 branches, supported by the customer centric products of BAGICL.

Karnataka Banks net profit fell 29.3% to Rs 68.52 crore on 6.4% increase in total income to Rs 1457.52 crore in Q3 December 2016 over Q3 December 2015.

Karnataka Bank is a private sector bank in India.

Powered by Capital Market - Live News

Uniply Industries gains on fund raising plan
Mar 14,2017

The announcement was made on Monday, 13 March 2017, when the stock market was shut on account of a public holiday.

Meanwhile, the S&P BSE Sensex was up 474.81 points, or 1.64% to 29,421.04.

On the BSE, 1,313 shares were traded in the counter so far, compared with average daily volumes of 12,109 shares in the past one quarter. The stock had hit a high of Rs 319 and a low of Rs 311.30 so far during the day.

The stock hit a 52-week high of Rs 350.90 on 27 February 2017. The stock hit a 52-week low of Rs 139.50 on 8 April 2016.

The stock had outperformed the market over the past one month till 10 March 2017, rising 16.12% compared with 2.18% rise in the Sensex. The scrip had also also outperformed the market in past one quarter, 48.13% as against Sensexs 8.22% rise.

The small-cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 10

Net profit of Uniply Industries rose 117.53% to Rs 2.11 crore on 3.47% rise in net sales to Rs 34.87 crore in Q3 December 2016 over Q3 December 2015.

Uniply Industries is engaged in the manufacture, marketing and trade of plywood, laminates and allied products in India.

Powered by Capital Market - Live News

NBCC (India) gains after securing contract
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P Sensex was up 509.35 points, 1.76% to 29,455.58.

On the BSE, 83,000 shares were traded on the counter so far as against the average daily volumes of 2.59 lakh shares in the past one quarter. The stock had hit a high of Rs 178.20 and a low of Rs 173.55 so far during the day.

The stock had hit a record high of Rs 199.47 on 5 October 2016 and a 52-week low of Rs 117.67 on 24 June 2016. The stock had underperformed the market over the past one month till 10 March 2017, declining 9.28% compared with the Sensexs 2.16% rise. The scrip had, however, outperformed the market over the past one quarter advancing 9.65% as against the Sensexs 8.22% rise.

The large-cap company has equity capital of Rs 180 crore. Face value per share is Rs 2.

NBCC (India) announced that the company has signed an agreement on Friday 10 March 2017, with the State of Mauritius (Government of Mauritius) and Landscope (Mauritius) for construction of new supreme court building on PMC basis in Mauritius. The approximate value of the project is Rs 250 crore having completion period of 24 months.

NBCC (India)s consolidated net profit rose 15.9% to Rs 64.42 crore on 4% increase in net sales to Rs 1413.77 crore in Q3 December 2016 over Q3 December 2015.

NBCC (India) is a blue-chip Government of India (GoI) Navratna Enterprise under the Ministry of Urban Development, in construction sector. The GoI held 75% stake in the firm (as per shareholding pattern as on 22 February 2017).

Powered by Capital Market - Live News

Power Grid Corporation gains as board accords investment approval
Mar 14,2017

The announcement was made on Saturday, 11 March 2017.

Meanwhile, the S&P BSE Sensex was up 452.51 points or 1.56% at 29,401.55

On BSE, so far 28,000 shares were traded in the counter as against average daily volume of 3.99 lakh shares in the past one quarter. The stock hit a high of Rs 198.30 and a low of Rs 195.20 so far during the day. The stock had hit a record high of Rs 209 on 22 February 2017. The stock had hit a 52-week low of Rs 136.30 on 18 March 2016.

The large-cap company has equity capital of Rs 5231.59 crore. Face value per share is Rs 10.

Power Grid Corporation of Indias net profit rose 20.16% to Rs 1930.02 crore on 23.94% increase in total income to Rs 6787.51 crore in Q3 December 2016 over Q3 December 2015.

Power Grid Corporation of India is a state run electric power transmission utility company. The Government of India holds 57.9% stake in the firm as at 31 December 2016.

Powered by Capital Market - Live News

ACC gains after selling shares in Shiva Cements
Mar 14,2017

The announcement was made after market hours on Friday, 10 March 2017.

Meanwhile, the S&P BSE Sensex was up 453.07 points, or 1.57% to 29,399.30.

On the BSE, 5,246 shares were traded in the counter so far, compared with average daily volumes of 18,870 shares in the past one quarter. The stock had hit a high of Rs 1,428.40 and a low of Rs 1,409.20 so far during the day.

The stock hit a 52-week high of Rs 1,738 on 8 August 2016. The stock hit a 52-week low of Rs 1,218.60 on 11 March 2016.

The stock had underperformed the market over the past one month till 10 March 2017, falling 5.78% compared with 2.18% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 1.48% as against Sensexs 8.22% rise.

The large-cap cement major has equity capital of Rs 187.79 crore. Face value per share is Rs 10.

ACC announced that it has on 9 March 2017, sold its entire 12.13% stake in Shiva Cement, comprising 2.36 crore shares, at a total consideration of Rs 38.66 crore to JSW Cement. The open market transaction took place at Rs 16.35 per share. The transaction is part of an earlier share purchase agreement (SPA) dated 15 February 2017, entered into between the company and JSW Cement. ACC was holding 12.13% in Shiva Cement in the public shareholders (non-promoter) category.

Shiva Cement had executed a SPA with JSW Cement in January this year for sale of shares held by the promoters of Shiva Cement, followed by an open offer to the public shareholders of Shiva Cement, to enable JSW Cement to get a controlling stake in the Odisha-based company. JSW Cement had agreed to buy a 35.6% stake from Shiva Cements promoters for Rs 97.24 crore. Further, JSW Cement had made an open offer to the public equity shareholders of Shiva Cement to acquire up to 6.24 crore fully paid-up equity shares, constituting 32% of the total fully diluted voting equity share capital of the company.

The total promoter holding in Shiva Cement end December 2016 stood at 35.62%. Shiva Cement runs an integrated plant near Rourkela in Odisha. It sells cement under the Sumangal brand and caters primarily to the eastern states.

ACCs consolidated net profit declined 44.98% to Rs 56.34 crore on 6.13% fall in net sales to Rs 2671.61 crore in Q4 December 2016 over Q4 December 2015.

ACC is a manufacturer of cement and concrete and is a member of LafargeHolcim group. The company has a countrywide network of modern cement and concrete plants, sales offices, dealers and retailers.

Powered by Capital Market - Live News